GLP-1 receptor agonistsincluding semaglutide (Ozempic, Wegovy) and liraglutide (Victoza, Saxenda)along with tirzepatide (Mounjaro, Zepbound), a dual GIP/GLP-1 receptor agonist, have transformed the management of type 2 diabetes and obesity
2026 Jan 29
Chit xut tr xanh, l hi, cam tho: Lm du da, chng vim, khng khun
That means that higher doses produce bigger results
Semaglutide works by mimicking a hormone that targets areas of the brain regulating appetite and food intake, making individuals feel less hungry and thus aiding in weight loss
Your healthcare team may implement additional monitoring strategies, such as more frequent clinical reviews and patient education about warning symptoms